-
Piracy attacks off Somalia surge in 2026: AFP analysis of IMO data
-
Two killed, one arrested, at school near Berlin: police
-
Tottenham land Marmoush from Manchester City
-
Cox defies Pakistan after Abbas's treble strike rocks England
-
YZi Labs Backs TermMax to Advance On-Chain Bond Market Infrastructure
-
Bosnian Serb war criminal Ratko Mladic dead
-
Nvidia boosts tech stocks but caution dominates ahead of Fed speech
-
Ogura to miss Aragon MotoGP after hand surgery
-
Pogacar holds off Mas to claim Vuelta stage six victory
-
Severe Thunderstorms Hit Eastern Australia After SA Deluge
-
A lasting Dolly Parton legacy: childhood literacy
-
More than goals: What Mourinho wants from Real Madrid's Mbappe
-
S.Africa sounds alarm as infant vaccinations plummet
-
Finland defends shores against oil spill risk
-
Toulouse have salary cap fine reduced on appeal
-
Iraola hoping for 'good news soon' in Liverpool pursuit of Barcola
-
Tech stocks lifted by Nvidia but caution dominates ahead of Fed speech
-
Iran executes over 500 people in 2026: rights group
-
'Smart cricketer' Dinusha helps Sri Lanka draw second India Test
-
Srebrenica: Massacre that outraged the world
-
Zambia opposition leader surrenders to police: state media
-
After US settlement, EU says Meta must 'protect our kids too'
-
Alleged 9/11 mastermind to go on trial in June 2028
-
Germany-led 'frugal' EU states demand budget plan cuts of 'several hundred billion'
-
Abbas's treble strike rocks England in second Test
-
Ratko Mladic: Serb crusader dubbed 'epitome of evil'
-
'Butcher of Bosnia' Ratko Mladic dead: Serbian state media
-
Pramac Yamaha replace Miller with Guevara for 2027 MotoGP season
-
New Zealand make three changes for second South Africa Test
-
Bouaddi needs time at Man City despite 100m euro fee, says Maresca
-
Stocktwits Expands CME Group Alliance with the Integration of Single Stock Futures Data
-
MEXC Launches SHEIN Subscription with $1M Quota as Inaugural IPO Express Event
-
'Mature' Colapinto extends contact with Alpine through 2027
-
Iran, Qatar hold Hormuz talks as US blockade chokes Iran oil imports
-
Atletico rule out any talks with Barcelona over Alvarez
-
Defiant Dinusha helps Sri Lanka draw second India Test
-
Tech stocks lifted by Nvidia as broader markets struggle
-
Pakistan bowl against England in rain-delayed second Test
-
Delap joins Nottingham Forest in club-record deal
-
Barcola move from PSG to Liverpool 'on track': source
-
ICC President Akane Warns U.S. Sanctions Threaten Court's Future
-
Swallowed by silt: Survivors recount Nepal flood horror
-
Delays in Cancer Radiotherapy and Surgery Target Times
-
Germany's Merz hosts 'frugal' leaders ahead of EU budget battle
-
Acrid stench, charred walls reveal devastation of Pakistan infant ward fire
-
Barca sign Croatia goalkeeper Livakovic
-
Norway holds its breath as King Harald's health deteriorates
-
Rain delays England's bid to put off-field incidents behind them
-
Germany reports record 15,800 heat-related deaths this summer
-
World record holder Sawe withdraws from Berlin Marathon
France warns against weight loss supplements using Garcinia plant
France warned Wednesday against dietary supplements promising weight loss that use the tropical plant Garcinia cambogia after a range of rare but serious side effects including one death were reported.
Garcinia cambogia -- which is also called Garcinia gummi-gutta or Malabar tamarind -- grows in India and Southeast Asia and has a fruit that looks like a pumpkin.
A range of supplements are sold around the world using extracts from the plant advertising its ability to suppress appetite and drive weight loss -- claims not backed by comprehensive scientific evidence.
After investigating the death of a person who took a Garcinia-based supplement -- and looking at other side effects reported in the United States and elsewhere -- French food safety agency ANSES said it "strongly advises" people against consuming the plant.
The plant has been banned from being used medicine since 2012 in France, but continues to be advertised in more 340 dietary supplements, which are mostly available online, the agency said in a statement.
There were 38 cases of serious side effects affecting the liver, pancreas, heart, muscles and mental health reported in France between 2009 and March last year, ANSES said.
These side effects can affect people with a history of psychiatric disorders, pancreatitis or hepatitis -- or who suffer from diabetes, obesity or high blood pressure, the agency added.
People taking antidepressants, antiretrovirals or drugs that affect the liver can also experience side effects.
A 71-year-old woman in France taking blood pressure drugs died of acute hepatitis in 2019 after taking Garcinia-based supplement Slim Metabol. ANSES says her death was "very likely" linked to the supplement, which remains on sale.
However people without a history of health problems can also be affected.
"A 32-year-old woman with no medical history developed myocarditis that led to her requiring a heart transplant," Aymeric Dopter, head of the ANSES nutrition risk assessment unit, told AFP.
"Some people will tell you: 'I took it and I am fine'," Dopter said.
"But we can see from these few cases that people who were simply trying to lose weight ended up with seriously impaired health -- or even died," he said.
"It is not the worth the risk."
The safety of products using Garcinia cambogia is currently being assessed by the European Food Safety Agency.
The watchdog is also investigating the risk of hydroxycitric acid, an ingredient extracted from the Garcinia plant's fruit, which is also used in supplements promoting weight loss.
France's ANSES called for the list of plants authorised for use in food supplements to be "harmonised" across the European Union.
S.Gantenbein--VB